公司概覽
業務類別 Biotechnology
業務概覽 Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
公司地址 50 Broadway, 7th Floor, London, GBR, SW1H 0BD
電話號碼 +44 2074003347
傳真號碼 --
公司網頁 https://www.roivant.com
員工數量 721
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Dr. Frank M. Torti, M.D. Co-President 美元 725.00K 29/07/2026
Dr. Eric Venker, M.D.,Pharm.D. Co-President; Chief Executive Officer, Immunovant 美元 75.00K 29/07/2026
Mr. Matthew Gline Chief Executive Officer and Director 美元 725.00K 29/07/2026
Dr. Mayukh Sukhatme Co-President, Chief Investment Officer and Director 美元 550.00K 29/07/2026
Mr. Richard Pulik Chief Financial Officer 美元 450.88K 29/07/2026
Ms. Jennifer Humes Chief Accounting Officer; Chief Accounting Officer of Roivant Sciences, Inc. -- 29/07/2026
 
董事會成員
董事會 職務 更新日期
Mr. James C. Momtazee Independent Director 29/07/2026
Dr. Meghan M. Fitzgerald, Ph. Independent Director 29/07/2026
Mr. Keith Manchester, M.D. Independent Director 29/07/2026
Mr. Ilan Oren Chairman of the Board 29/07/2026
Ms. Melissa B. Epperly Independent Director 29/07/2026
Mr. Daniel Gold Independent Director 29/07/2026
Mr. Matthew Gline Chief Executive Officer and Director 29/07/2026
Dr. Mayukh Sukhatme Co-President, Chief Investment Officer and Director 29/07/2026
 
所屬ETF (更新日期: 11/11/2026 03:45)
代號 名稱 佔比% ▼ 持有日期
MVVProShares Ultra MidCap4000.003%30/10/2026
DFALDimensional US Large Cp Cor Eq Mkt ETF0.003%30/10/2026
PAMCPacer Lunt MidCap Multi-Factor Alt ETF0.002%30/10/2026
SMOXHorizon Small/Mid Cap Core Equity ETF0.002%30/10/2026
GUSAGoldman Sachs MarketBeta US 1000 Eq ETF0.002%30/10/2026
GDOCGoldman Sachs Future Health Care Eq ETF0.002%30/10/2026
AVLCAvantis U.S. Large Cap Equity ETF0.002%30/10/2026
TILTNorthern Trust Mstar US Mkt Fac Tlt ETF0.002%30/10/2026
PJFMPGIM Jennison Focused Mid-Cap ETF0.002%30/10/2026
ILCViShares Morningstar Value ETF0.002%30/10/2026
BLESInspire Global Hope ETF0.002%30/10/2026
TAXCambria Tax Aware ETF0.001%30/10/2026
JHMLJHancock Multifactor Large Cap ETF0.001%30/10/2026
MLRGiShares MSCI USA ETF0.001%21/10/2026
CVLCCalvert US Large-Cp Cor Rspnb ETF0.001%30/10/2026
VOTETCW Transform 500 ETF0.001%30/10/2026
OMFLInvesco Russell 1000® Dynamic Mltfct ETF0.001%30/10/2026
MSSMMorgan Stanley Pathway Sm-Md Cp Eq ETF0.001%31/10/2026
MIDUDirexion Daily Mid Cap Bull 3X ETF0.001%31/10/2026
GVUSGoldman Sachs MktBt Russell LgCpValEqETF0.001%30/10/2026
  1    2    3    4    5   6    7    8    9  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.